Uckerman, Mary

Uckerman, Mary was paid $4.20M by Medicaid between Jan 2018 and Dec 2024, across 180 billing codes. Its largest line is 87635, Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe — 11% of everything it billed.

33Billing provider infoUCKERMAN, MARY
MELROSE PARK, IL 60160

33aNPI1801809322assigned 08/14/2006

33bProvider typeClinical Pathology/Laboratory Medicine Physician

28Total paid$4.20M

24GClaims614,498

24DCodes billed180

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Clinical Pathology/Laboratory Medicine Physician providers in Illinois

Rank by total paid#4 of 34

Median peer was paid$104K

This provider vs. median40×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	284	$4K
2019	93,742	$481K
2020	79,879	$370K
2021	78,738	$647K
2022	136,926	$1.17M
2023	115,359	$856K
2024incomplete	109,570	$676K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	11%	12,029	10,244	$458K
80053	Comprehensive metabolic panel	6.2%	51,947	34,965	$262K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	5.8%	3,678	3,066	$242K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	5.4%	4,845	4,603	$228K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	5.0%	73,516	43,981	$210K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	4.5%	8,827	8,403	$191K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	4.5%	8,793	8,383	$190K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	4.5%	8,071	6,930	$187K
83735		3.0%	37,312	17,693	$126K
80048	Basic metabolic panel (calcium, ionized)	2.7%	28,097	14,911	$114K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	2.6%	1,489	1,450	$108K
84484		2.3%	18,799	14,762	$96K

168 more codes

82805		2.1%	3,986	$90K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	2.0%	5,725	$86K
83880		2.0%	7,991	$85K
84443	Thyroid stimulating hormone (TSH)	1.8%	9,544	$77K
87040		1.6%	6,171	$68K
88305	Level IV - Surgical pathology, gross and microscopic examination	1.5%	2,229	$65K
87086	Culture, bacterial; quantitative colony count, urine	1.5%	12,389	$62K
88307		1.4%	872	$58K
86850		1.4%	7,319	$58K
82962		1.1%	27,785	$47K
83605		1.0%	8,078	$44K
83690		1.0%	12,919	$43K
85730		<1%	8,617	$28K
87081		<1%	9,975	$28K
87480		<1%	2,038	$26K
87510		<1%	2,008	$26K
86901		<1%	11,612	$25K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	1,207	$25K
86803		<1%	3,157	$25K
84100		<1%	13,159	$25K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	1,104	$24K
85027		<1%	8,632	$24K
81003		<1%	22,980	$24K
80061	Lipid panel	<1%	5,970	$21K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	2,768	$21K
87186		<1%	3,623	$21K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	2,351	$20K
84702		<1%	4,313	$20K
86900		<1%	11,615	$19K
82803		<1%	1,952	$19K
85610		<1%	9,673	$19K
87660		<1%	2,217	$18K
83036	Hemoglobin; glycosylated (A1C)	<1%	5,790	$18K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	696	$17K
87340		<1%	2,673	$17K
85379		<1%	4,403	$16K
87641		<1%	809	$16K
82607		<1%	2,715	$16K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	101	$16K
88342		<1%	865	$16K
83021		<1%	2,437	$15K
82261		<1%	1,829	$15K
83498		<1%	1,925	$14K
80202		<1%	1,910	$13K
80076		<1%	4,214	$13K
82728		<1%	3,047	$12K
82746		<1%	2,124	$12K
82542		<1%	1,569	$11K
82550		<1%	4,882	$11K
83789		<1%	1,482	$10K
84466		<1%	2,320	$10K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	693	$10K
84145		<1%	1,401	$10K
86140		<1%	3,802	$9K
81514		<1%	219	$8K
82553		<1%	2,485	$8K
84439		<1%	1,881	$8K
83516		<1%	1,631	$8K
80081		<1%	259	$8K
82247		<1%	3,329	$8K
83540		<1%	2,350	$7K
82077		<1%	664	$7K
82248		<1%	3,561	$7K
86920		<1%	1,722	$7K
87210		<1%	3,144	$7K
82570		<1%	3,054	$7K
86356		<1%	478	$7K
87147		<1%	2,353	$7K
86592		<1%	3,217	$6K
86880		<1%	2,194	$6K
86762		<1%	1,317	$6K
83615		<1%	2,328	$6K
87070		<1%	1,757	$5K
82776		<1%	1,507	$5K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	159	$5K
81001		<1%	3,885	$5K
83970		<1%	286	$4K
82150		<1%	1,272	$4K
81025		<1%	1,515	$4K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	101	$4K
86780		<1%	476	$4K
87807		<1%	690	$3K
82565		<1%	1,640	$3K
80074		<1%	177	$3K
84550		<1%	1,790	$3K
85652		<1%	2,407	$3K
87075		<1%	522	$3K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	139	$3K
86038		<1%	369	$3K
87205		<1%	1,387	$3K
84156		<1%	2,300	$3K
82950		<1%	1,076	$2K
86706		<1%	362	$2K
87486		<1%	101	$2K
86787		<1%	316	$2K
88313		<1%	93	$2K
87581		<1%	101	$2K
83919		<1%	269	$2K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	124	$2K
87449		<1%	137	$2K
86480		<1%	65	$2K
82375		<1%	671	$1K
87493		<1%	62	$1K
83001		<1%	148	$1K
82105		<1%	164	$1K
84403		<1%	101	$1K
85018		<1%	1,160	$1K
85014		<1%	1,072	$1K
87529		<1%	26	$1K
81420	Fetal chromosomal aneuploidy genomic sequence analysis panel	<1%	26	$1K
82009		<1%	794	$962.66
84146		<1%	138	$959.62
82140		<1%	244	$956.37
82043		<1%	448	$877.65
85384		<1%	292	$851.97
84300		<1%	391	$835.20
82330		<1%	118	$821.64
86235		<1%	14	$767.00
82128		<1%	315	$765.00
82760		<1%	326	$729.29
88341		<1%	27	$727.65
85045		<1%	570	$718.52
80179		<1%	55	$682.18
80143		<1%	55	$682.18
86885		<1%	238	$680.15
88112		<1%	29	$664.34
82016		<1%	253	$606.90
87077		<1%	185	$576.18
87088		<1%	95	$493.00
86225		<1%	72	$424.80
84478		<1%	256	$413.61
80069		<1%	102	$393.13
86160		<1%	42	$392.72
80055		<1%	27	$377.04
82670		<1%	37	$322.94
83930		<1%	124	$316.88
84703		<1%	90	$304.30
87150		<1%	16	$270.00
84132		<1%	185	$252.66
85060		<1%	25	$247.89
86870		<1%	31	$222.27
80164		<1%	49	$212.64
82784		<1%	16	$208.84
88141		<1%	16	$202.13
81015		<1%	138	$180.78
80050	General health panel	<1%	592	$170.40
86431		<1%	46	$151.45
84144		<1%	19	$150.24
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	15	$129.36
82533		<1%	18	$118.77
83020		<1%	24	$99.13
86593		<1%	47	$94.00
84425		<1%	13	$92.12
83002		<1%	15	$83.40
86704		<1%	14	$83.21
86200		<1%	15	$78.50
88312		<1%	13	$64.64
82785		<1%	13	$63.37
86376		<1%	13	$56.80
85520		<1%	18	$53.55
80305		<1%	12	$49.39
83935		<1%	14	$32.62
84165		<1%	14	$31.50
84450		<1%	12	$26.20
84460		<1%	12	$25.90
89050		<1%	12	$24.50
84520		<1%	13	$21.23
82272		<1%	13	$16.51

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.